Responses
Regular and Young Investigator Award Abstracts
Combination Immunotherapies
835 Heterologous prime boost viral vector vaccination provides protection against intracranial syngeneic murine glioblastoma
Compose a Response to This Article
Other responses
No responses have been published for this article.
